GD
59
-5
WEC
46
-4
IR
74
-5
PLD
61
-3
DHI
57
-4
ED
30
-3
GRMN
59
-3
M
36
2
DUK
59
-5
KIM
54
-6
AAP
24
-3
SNA
53
-2
VIX
25
-8
UHS
58
-2
CAH
48
-5
WBA
31
-4
FTI
84
2
DE
25
-4
CSX
44
-4
GILD
47
-3
GD
59
-5
WEC
46
-4
IR
74
-5
PLD
61
-3
DHI
57
-4
ED
30
-3
GRMN
59
-3
M
36
2
DUK
59
-5
KIM
54
-6
AAP
24
-3
SNA
53
-2
VIX
25
-8
UHS
58
-2
CAH
48
-5
WBA
31
-4
FTI
84
2
DE
25
-4
CSX
44
-4
GILD
47
-3
Financhill
Back

Grupo Aeroportuario del Centro Norte SAB de CV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
38

OMAB
Grupo Aeroportuario del Centro Norte SAB de CV

Last Price:
69.39
Seasonality Move:
4.11%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
38
Grupo Aeroportuario del Centro Norte SAB de CV (OMAB) is a Sell

Is Grupo Aeroportuario del Centro Norte SAB de CV a Buy, Sell or Hold?

  • The current Grupo Aeroportuario del Centro Norte SAB de CV [OMAB] share price is $69.34. The Score for OMAB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • OMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OMAB Stock Price Chart

What is Grupo Aeroportuario del Centro Norte SAB de CV's stock price today?

  • The Grupo Aeroportuario del Centro Norte SAB de CV share price today is $69.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

OMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.22 Sell
Chaikin Money Flow: 36402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.69 - 81.25) Sell
Bollinger Bands (100): (69.88 - 83.76) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

OMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.34 Buy
20-day SMA: 72.52 Sell
50-day SMA: 79.67 Sell
200-day SMA: 76.21 Sell
8-day EMA: 69.78 Sell
20-day EMA: 72.8 Sell
50-day EMA: 76.52 Sell
200-day EMA: 77.21 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Grupo Aeroportuario del Centro Norte SAB de CV Earnings Growth & OMAB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.13 per share, and an increase next year of $0.68 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Grupo Aeroportuario del Centro Norte SAB de CV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):